RU2013122649A - Способ радиоактивного коньюгирования - Google Patents
Способ радиоактивного коньюгирования Download PDFInfo
- Publication number
- RU2013122649A RU2013122649A RU2013122649/04A RU2013122649A RU2013122649A RU 2013122649 A RU2013122649 A RU 2013122649A RU 2013122649/04 A RU2013122649/04 A RU 2013122649/04A RU 2013122649 A RU2013122649 A RU 2013122649A RU 2013122649 A RU2013122649 A RU 2013122649A
- Authority
- RU
- Russia
- Prior art keywords
- formula
- compound
- peptide
- cys
- radioisotope
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/008—Peptides; Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/02—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/534—Production of labelled immunochemicals with radioactive label
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2318/00—Antibody mimetics or scaffolds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1020314.9A GB201020314D0 (en) | 2010-12-01 | 2010-12-01 | Apoptosis pet imaging agents |
| GB1020314.9 | 2010-12-01 | ||
| US201161476805P | 2011-04-19 | 2011-04-19 | |
| GBGB1106593.5A GB201106593D0 (en) | 2011-04-19 | 2011-04-19 | Radioconjugation method |
| GB1106593.5 | 2011-04-19 | ||
| US61/476,805 | 2011-04-19 | ||
| PCT/EP2011/071506 WO2012072736A2 (en) | 2010-12-01 | 2011-12-01 | Radioconjugation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2013122649A true RU2013122649A (ru) | 2015-01-10 |
Family
ID=45063153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013122649/04A RU2013122649A (ru) | 2010-12-01 | 2011-12-01 | Способ радиоактивного коньюгирования |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9493504B2 (https=) |
| EP (2) | EP2646060B1 (https=) |
| JP (1) | JP6231882B2 (https=) |
| KR (1) | KR20130119957A (https=) |
| CN (2) | CN104984372B (https=) |
| AU (1) | AU2011334881A1 (https=) |
| BR (1) | BR112013013283A2 (https=) |
| CA (1) | CA2819347A1 (https=) |
| ES (2) | ES2675102T3 (https=) |
| MX (1) | MX2013006202A (https=) |
| RU (1) | RU2013122649A (https=) |
| WO (1) | WO2012072736A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2013122649A (ru) * | 2010-12-01 | 2015-01-10 | ДжиИ ХЕЛТКЕР ЛИМИТЕД | Способ радиоактивного коньюгирования |
| GB201314936D0 (en) * | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
| GB201322451D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Purification method and compositions |
| GB201322456D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
| EP3743116B1 (en) * | 2018-01-26 | 2024-07-10 | F. Hoffmann-La Roche AG | Radiolabelled oligonucleotides and process for their preparation |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996040662A2 (en) * | 1995-06-07 | 1996-12-19 | Cellpro, Incorporated | Aminooxy-containing linker compounds and their application in conjugates |
| GB0305704D0 (en) * | 2003-03-13 | 2003-04-16 | Amersham Plc | Radiofluorination methods |
| WO2005072778A2 (en) * | 2004-01-29 | 2005-08-11 | Biosynexus, Inc. | Use of amino-oxy functional groups in the preparation of vaccines conjugates |
| GB0420344D0 (en) | 2004-09-14 | 2004-10-13 | Amersham Plc | Diagnostic compounds |
| GB0420365D0 (en) | 2004-09-14 | 2004-10-13 | Hammersmith Imanet Ltd | Radiolabelled insulin |
| EP2125039A2 (en) | 2006-12-18 | 2009-12-02 | GE Healthcare AS | Synthesis of a radiofluorinated peptide using photolabile protecting groups |
| EP2114464A2 (en) * | 2006-12-28 | 2009-11-11 | GE Healthcare AS | Radiofluorination methods |
| US8545809B2 (en) * | 2007-01-11 | 2013-10-01 | Immunomedics, Inc. | Methods and compositions for improved 18F labeling of proteins, peptides and other molecules |
| US20080274046A1 (en) * | 2007-02-20 | 2008-11-06 | Christian Prenant | Radiolabelling |
| GB0803477D0 (en) | 2008-02-26 | 2008-04-02 | Ge Healthcare As | Therapy selection method |
| RU2013122649A (ru) * | 2010-12-01 | 2015-01-10 | ДжиИ ХЕЛТКЕР ЛИМИТЕД | Способ радиоактивного коньюгирования |
-
2011
- 2011-12-01 RU RU2013122649/04A patent/RU2013122649A/ru not_active Application Discontinuation
- 2011-12-01 KR KR1020137016889A patent/KR20130119957A/ko not_active Withdrawn
- 2011-12-01 WO PCT/EP2011/071506 patent/WO2012072736A2/en not_active Ceased
- 2011-12-01 AU AU2011334881A patent/AU2011334881A1/en not_active Abandoned
- 2011-12-01 JP JP2013541350A patent/JP6231882B2/ja active Active
- 2011-12-01 US US13/991,340 patent/US9493504B2/en active Active
- 2011-12-01 EP EP11788862.8A patent/EP2646060B1/en active Active
- 2011-12-01 ES ES11788862.8T patent/ES2675102T3/es active Active
- 2011-12-01 CA CA2819347A patent/CA2819347A1/en not_active Abandoned
- 2011-12-01 CN CN201510440109.1A patent/CN104984372B/zh active Active
- 2011-12-01 ES ES18167523T patent/ES2929507T3/es active Active
- 2011-12-01 BR BR112013013283A patent/BR112013013283A2/pt not_active IP Right Cessation
- 2011-12-01 CN CN201180057989.4A patent/CN103269725B/zh active Active
- 2011-12-01 EP EP18167523.2A patent/EP3395373B1/en active Active
- 2011-12-01 MX MX2013006202A patent/MX2013006202A/es unknown
-
2016
- 2016-11-01 US US15/340,743 patent/US20170044080A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2646060B1 (en) | 2018-05-30 |
| AU2011334881A1 (en) | 2013-06-06 |
| CN104984372A (zh) | 2015-10-21 |
| ES2675102T3 (es) | 2018-07-06 |
| CN103269725B (zh) | 2015-09-23 |
| US9493504B2 (en) | 2016-11-15 |
| US20170044080A1 (en) | 2017-02-16 |
| JP6231882B2 (ja) | 2017-11-15 |
| JP2014500883A (ja) | 2014-01-16 |
| CN103269725A (zh) | 2013-08-28 |
| EP3395373A1 (en) | 2018-10-31 |
| EP3395373B1 (en) | 2022-10-19 |
| ES2929507T3 (es) | 2022-11-29 |
| WO2012072736A3 (en) | 2012-10-18 |
| MX2013006202A (es) | 2013-07-29 |
| BR112013013283A2 (pt) | 2016-11-22 |
| CN104984372B (zh) | 2018-11-09 |
| US20130259803A1 (en) | 2013-10-03 |
| WO2012072736A2 (en) | 2012-06-07 |
| KR20130119957A (ko) | 2013-11-01 |
| EP2646060A2 (en) | 2013-10-09 |
| CA2819347A1 (en) | 2012-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Valverde et al. | 1, 2, 3-Triazoles as amide bond mimics: triazole scan yields protease-resistant peptidomimetics for tumor targeting. | |
| TWI515011B (zh) | 鈴蟾素類似物胜肽拮抗劑共軛物 | |
| KR102498607B1 (ko) | 방사성표지 ｈｅｒ２ 결합 펩티드 | |
| US10201625B2 (en) | Radiolabelled octreotate analogues as PET tracers | |
| US20180037608A1 (en) | Modified cyclopentapeptides and uses thereof | |
| RU2013122649A (ru) | Способ радиоактивного коньюгирования | |
| RU2013128360A (ru) | Her2-связывающие белки, меченые 18f-содержащим кремнийорганическим соединением | |
| US9259496B2 (en) | Technetium labelled peptides | |
| JP2022529007A (ja) | 診断及び治療のための新規な放射性標識されたｃｘｃｒ４を標的とする化合物 | |
| IL301342A (en) | Novel cxcr4-targeting compounds | |
| JP2014500883A5 (https=) | ||
| EP2895204B1 (en) | Compositions targeting bradykinin receptor b1 for medical imaging of cancer and other disorders | |
| IL312105A (en) | Gastric inhibitory peptide receptor ligands | |
| US20240018110A1 (en) | Radiolabeled compounds targeting the prostate-specific membrane antigen | |
| ES2764119T3 (es) | Método de radiomarcaje | |
| JP7221937B2 (ja) | 腫瘍標的化ペプチドバリアント | |
| IL312107A (en) | Cd73 compounds | |
| TW202541853A (zh) | 增濃且安定之放射配體治療調製劑及包含彼之醫藥組成物 | |
| IL312106A (en) | Combination therapy of radionuclide complex | |
| Shirmardi et al. | Preparation and evaluation of 67Ga-DOTA-Bombesin (7-14) as a tumor scintigraphic agent | |
| HK1212610B (en) | Compositions targeting bradykinin receptor b1 for medical imaging of cancer and other disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20141202 |